Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antitumor Activity”

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06979674
What this trial is testing

Study of ESG406 in Adults With Solid Tumors

Who this might be right for
Locally Advanced/Metastatic Solid Tumors
Shanghai Escugen Biotechnology Co., Ltd 556
Early research (Phase 1)Looking for participantsNCT07617727
What this trial is testing

A Phase I Study of JSKN021 in Advanced Solid Tumors

Who this might be right for
Advanced Malignant Solid Tumors
Jiangsu Alphamab Biopharmaceuticals Co., Ltd 199
Early research (Phase 1)Study completedNCT03713905
What this trial is testing

Study of Recombinant Human Anti-PD-1 Monoclonal Antibody for Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Guangzhou Gloria Biosciences Co., Ltd. 293
Testing effectiveness (Phase 2)Study completedNCT04332744
What this trial is testing

Enzalutamide Plus Talazoparib for the Treatment of Hormone Sensitive Prostate Cancer (ZZ-First)

Who this might be right for
Metastatic Prostate Cancer
MedSIR 54
Early research (Phase 1)Looking for participantsNCT07181681
What this trial is testing

A First-in-Human Study of BG-C0902 Alone and in Combination With Other Therapeutic Agents in Patients With Advanced Solid Tumors

Who this might be right for
Solid TumorsAdvanced Solid Tumor
BeOne Medicines 63
Not applicableLooking for participantsNCT05007379
What this trial is testing

Study to Determine the Antitumor Activity of New CAR-macrophages in Breast Cancer Patients' Derived Organoids

Who this might be right for
Breast Cancer
Centre Oscar Lambret 100
Testing effectiveness (Phase 2)Study completedNCT02648724
What this trial is testing

Sym015 (Anti-MET) in Patients With Advanced Solid Tumor Malignancies

Who this might be right for
OncologyMET Gene AmplificationNSCLC+2 more
Symphogen A/S 57
Early research (Phase 1)Looking for participantsNCT07807241
What this trial is testing

MX006 in Patients With Advanced and/or Metastatic Tumors Known to Express B7-H3

Who this might be right for
Advanced and/or Metastatic Solid Tumors Known to Express B7-H3
Myricx Pharma Limited 120
Early research (Phase 1)UnknownNCT03125746
What this trial is testing

LXI-15029 in Patients With Advanced Malignant Solid Tumors

Who this might be right for
Advanced Breast Cancer
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. 72
Early research (Phase 1)Ended earlyNCT06289894
What this trial is testing

BRY805 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
BioRay Pharmaceutical Co., Ltd. 13
Early research (Phase 1)Not Yet RecruitingNCT07686445
What this trial is testing

AN4035 in Advanced Cancers With RAS Mutations and High CEACAM5 Expression

Who this might be right for
Solid Tumor (Phase I)RAS MutationCEACAM5
Adlai Nortye Biopharma Co., Ltd. 228
Early research (Phase 1)UnknownNCT06094777
What this trial is testing

HY-0102 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Shanghai YingLi Pharmaceutical Co. Ltd. 50
Early research (Phase 1)WithdrawnNCT05263739
What this trial is testing

A First-in-Human Phase I Study of ESG206 in Subjects With B-cell Lymphoid Malignancies

Who this might be right for
B-cell Lymphoid Malignancies
Shanghai Escugen Biotechnology Co., Ltd
Early research (Phase 1)Ended earlyNCT05718219
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of SIM0348 in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Jiangsu Simcere Pharmaceutical Co., Ltd. 49
Early research (Phase 1)Looking for participantsNCT07249879
What this trial is testing

This Study is an Open-lable, Early Study to Evaluate the Safety, Feasibility, Cytokinetics, and Preliminary Efficacy of GC511B in DLL3+ Relapsed/Refractory Small Cell Lung Cancer.

Who this might be right for
Relapsed/Refractory Small Cell Lung Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 55
Early research (Phase 1)Looking for participantsNCT07561723
What this trial is testing

IMP3-saRNA Vaccine in Advanced NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
West China Hospital 9
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07104110
What this trial is testing

Study of QLH12016 in Combination With Novel Hormonal Agent in Subjects With Advanced Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Qilu Pharmaceutical Co., Ltd. 50
Early research (Phase 1)UnknownNCT04682808
What this trial is testing

FCN-338 in Patients With Chronic CLL/SLL

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Fochon Pharmaceuticals, Ltd. 99
Early research (Phase 1)UnknownNCT05818917
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Evidence of Antitumor Activity of FHND5071 as a Single Agent in Adult Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT04632108
What this trial is testing

A 1/2 Phase Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of ASKB589 in Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Malignant Solid Tumor
Jiangsu Aosaikang Pharmaceutical Co., Ltd. 199
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation